AkzoNobel and Shareholders Likely Headed to Dutch Court

The question of what specific agenda items will be voted on at an extraordinary general meeting, if AkzoNobel honors the meeting request of shareholders led by Elliott Advisors, could end up infeatured

Paulson Poised as Pivotal Teva-Mylan Shareholder

Paulson & Co. has upped its stake in Mylan NV to 4.65 percent, positioning the hedge fund as a key player in the three-continent pharmaceutical takeover battle involving Mylan, Teva Pharmaceutical Industries Ltd., and Perrigo Co. plc. The disclosure, filed last Friday with the Irish Takeover Panel, comes as Mylan’s special shareholder foundation, the Stichting … Read Morefeatured

Abbott Holds Critical Stake in Teva-Mylan Merger Tilt

Abbott Laboratories has emerged as a key player in the three-way battle being fought by drug manufacturing rivals Teva Pharmaceutical, Mylan N.V., and Perrigo Co. plc. The Chicago-based pharma giant still holds a 14 percent stake in Mylan that it obtained last year when Mylan acquired Abbott’s non-U.S. specialty and branded generics business in exchange … Read Morefeatured

X

Interested in a trial?

Simply fill out the form below and one of our representatives will be in touch.